HDAC9 and glioblastoma: In this work we provide evidence that the inhibition of HDAC activity disrupts the molecular signature of U87MG GBM cells secretome, focusing on the angiogenic Matrisome signature, the AngioMatrix, with critical functional impact on endothelial cell behavior and angiogenesis.